Advance Search
LIU Hua, MA Haijian, GONG Hongchao. Risk warning management in pregnant women with late threatened abortion by magnesium sulfate treatment[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 118-121. DOI: 10.7619/jcmp.202017032
Citation: LIU Hua, MA Haijian, GONG Hongchao. Risk warning management in pregnant women with late threatened abortion by magnesium sulfate treatment[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 118-121. DOI: 10.7619/jcmp.202017032
shu

Risk warning management in pregnant women with late threatened abortion by magnesium sulfate treatment

  • Department of Gynecology, Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, 225002

More Information
  • Received Date: May 25, 2020
  • Available Online: September 29, 2020
    Graphical Abstract
    • Abstract
  • Objective To observe effect of risk warning management in pregnant women with late threatened abortion by magnesium sulfate treatment. Methods A total of 22 pregnant women with late threatened abortion by treatment of magnesium sulfate from January to December 2019 were selected as observation group, and they were conducted with whole process risk warning management. Another 25 pregnant women without risk warning management before 2019 were selected as control group. The mastery degree of risk warning management indicators(score for mastery of drug knowledge, score for standard manipulations of magnesium sulfate and infusion pump, score for quality control inspection of high-risk drug management)of nurses in charge of pregnant women in both groups were compared. The satisfaction degree of pregnant women to nursing services, scores of Self-rating Anxiety Scale(SAS)and Self-rating Depression Scale(SDS), and nursing risk events were compared between the two groups. Results Score for mastery of drug knowledge, score for standard manipulations of magnesium sulfate and infusion pump, and score for quality control inspection of high-risk drug management of nurses in charge of pregnant women in the observation group were significantly higher than those in the control group(P<0.05). The satisfaction degree of pregnant women in the observation group was 90.91%(20/22), which was significantly higher than 64.00%(16/25)in the control group(P<0.05). The scores of SAS and SDS in the observation group were significantly lower than those in the control group(P<0.05). The incidence of nursing risk events in the observation group was significantly lower than that in the control group(P<0.05). Conclusion Risk warning management can effectively reduce the incidence of nursing risk events, enhance the risk awareness and prevention ability of nursing staffs, increase the satisfaction degree of pregnant women, and ensure safety of pregnant women.
    • FullText(HTML)
    • References (10)
  • 叶小丽, 吴志军, 许园姣. 不同宫缩抑制剂在先兆早产治疗中临床疗效与安全性的研究[J]. 中国妇幼健康研究, 2017, 28(8): 957-960.
    马燕, 陈丹青. 早产药物治疗的循证评价[J]. 实用妇产科杂志, 2019, 35(7): 489-491.
    刘爱莲. 盐酸利托君与硫酸镁治疗早产临床效果与安全性研究[J]. 世界最新医学信息文摘, 2019, 19(73): 134-135.
    马腾, 周莉. 硫酸镁对早产儿脑神经保护作用的研究进展[J]. 中国医刊, 2020, 55(2): 130-133.
    金晶, 邹丽. 硫酸镁对胎儿及新生儿的影响[J]. 妇产与遗传: 电子版, 2014, 4(1): 45-48.
    HANLEY M, SAYRES L, REIFF E S, et al, Tocolysis: a review of the literature[J]. Obstet Gynecol Surv, 2019, 74(1): 50-55.
    DOYLE LW, CROWTHER CA, MIDDLETON P, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus[J]. Cochrane Database Syst Rev, 2009(1): CD004661.
    刘洋铭, 王寒冰, 漆洪波. 美国妇产科医师学会早产管理指南2016年补充公告解读[J]. 中国实用妇科与产科杂志, 2016, 32(12): 1189-1192.
    韩雪玲, 杜晓琴. 硫酸镁对有早产风险孕妇胎儿神经保护的研究进展[J]. 继续医学教育, 2017, 31(6): 144-146.
    殷祝美. 盐酸利托君与硫酸镁治疗早产临床效果与安全性分析[J]. 临床合理用药杂志, 2017, 10(23): 61-62.
    • Related Articles

  • Cited by

    Periodical cited type(17)

    1. 赵江华，陈云，蒋珺. 体位变换在早产新生儿呼吸窘迫综合征机械通气患儿中的应用效果. 妇儿健康导刊. 2025(04): 143-146+155 .
    2. 代苗英，蓝菊红. CH50 CD3~+及CD4~+在新生儿急性呼吸窘迫综合征患儿中的表达及意义. 中国妇幼保健. 2024(01): 44-48 .
    3. 周丽平，苏红. 基于集束化理念的气道分级管理在新生儿呼吸窘迫综合征机械通气患儿中的应用. 中外医学研究. 2024(16): 85-89 .
    4. 牛曼玉. 预警机制联合转变体位护理在新生儿肺炎中的应用效果. 中国民康医学. 2024(14): 186-189 .
    5. 胡龙，贺蛟龙，时淑娟，黄聪灵. 右美托咪定与咪达唑仑在ICU急性呼吸窘迫综合征行俯卧位通气患者中的镇静效果比较. 临床合理用药. 2024(23): 17-20 .
    6. 徐海萍，潘利飞. 俯卧位通气对急性呼吸窘迫综合征患者氧合状态和谵妄发生率的影响. 中国医药导报. 2024(16): 59-61 .
    7. 董惠仪，李莉，成玉萍. 早产儿俯卧位机械通气在新生儿呼吸窘迫综合征中的临床疗效分析. 婚育与健康. 2024(18): 40-42 .
    8. 叶淮金. 新生儿急性呼吸窘迫综合征发病机制及俯卧位通气治疗的研究进展. 中国社区医师. 2024(26): 4-6 .
    9. 林娇蓉，李科霞，许翠雯. 强化风险护理联合俯卧位通气对新生儿呼吸窘迫综合征的影响. 中国医药指南. 2024(32): 64-66 .
    10. 王万旭，何学坤. 保护性机械通气治疗新生儿脓毒血症合并急性呼吸窘迫综合征效果研究. 中华养生保健. 2024(21): 56-59 .
    11. 再乃甫·乃比江，艾图尼克·沙马瓦提，阿布来提·阿不都哈尔. 儿童脓毒症相关急性呼吸窘迫综合征的早期识别与治疗进展. 中国医学创新. 2024(36): 171-175 .
    12. 钟艳玲，刘彦彦. 肺透明膜病新生儿经鼻持续正压通气治疗中压力不稳定发生情况及危险因素分析. 中国当代医药. 2023(08): 123-126 .
    13. 汤媛. 先天性胸腔积液合并呼吸窘迫综合征1例的护理. 中国乡村医药. 2023(06): 81-82 .
    14. 丘文英，林艺坤，甘跃华. 俯卧位机械通气在新生儿呼吸窘迫综合征中的临床疗效分析. 中外医疗. 2023(18): 57-60 .
    15. 左园弋. 俯卧位通气在急性呼吸窘迫综合征患者中的应用价值. 婚育与健康. 2023(18): 58-60 .
    16. 杜遥，张妙联，邓鸿儒. 俯卧位通气联合布地奈德应用于新生儿呼吸窘迫综合征的临床观察. 中国医学创新. 2023(34): 140-143 .
    17. 李眉，陶建兰，王伏东，翟秀玲. 新生儿肺透明膜病经鼻持续正压通气治疗中通气压力不稳定风险的列线图模型构建. 实用临床医药杂志. 2023(24): 63-67 . 本站查看

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML
    Article views (357) PDF downloads (14) Cited by(19)
    Turn off MathJax
    Article Contents
    Abstract
    References

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return